Mode
Text Size
Log in / Sign up

Rheumatology

369 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review and meta-analysis of machine learning models for deep vein thrombosis prediction in hospitalized adults
Rheumatology Meta-analysis
Systematic review and meta-analysis of machine learning models for deep vein thrombosis prediction in hospitalized adults Machine learning models predict blood clots in hospitalized adults with high accuracy
This systematic review and meta-analysis synthesized evidence on machine learning-based prediction models for deep vein thrombosis in hospit…
A new analysis of 17 studies shows machine learning models can predict deep vein thrombosis in hospitalized patients with an accuracy score …
Narrative review of AI and simulation in medical education for student-centered learning
Rheumatology Sys. Review
Narrative review of AI and simulation in medical education for student-centered learning New digital tools help medical students learn better than traditional classrooms
This narrative review synthesizes evidence on artificial intelligence and simulation-based education for medical students. It compares these…
A review suggests modern digital learning methods may improve engagement and understanding for medical students compared to standard lecture…
Systematic review and meta-analysis shows death education improves end-of-life care competence in nurses
Rheumatology Meta-analysis
Systematic review and meta-analysis shows death education improves end-of-life care competence in nurses Death education programs boost nurse confidence in end-of-life care skills
This systematic review and meta-analysis evaluated death education programs for nurses and nursing students. The analysis included 1,142 par…
A review of 13 studies found that death education programs significantly improved nurses confidence in providing end-of-life care, though ch…
FDA Approves Tofidence (tocilizumab-bavi) for Multiple Inflammatory Conditions and COVID-19
Rheumatology FDA Approval
FDA Approves Tofidence (tocilizumab-bavi) for Multiple Inflammatory Conditions and COVID-19 FDA approves new biosimilar drug Tofidence for arthritis and COVID-19.
FDA approved Tofidence (tocilizumab-bavi), an IL-6 receptor antagonist, for rheumatoid arthritis, giant cell arteritis, polyarticular juveni…
The FDA approved Tofidence (tocilizumab-bavi), a biosimilar to tocilizumab, for rheumatoid arthritis, giant cell arteritis, juvenile arthrit…
Case report of cefotaxime treatment for peritoneal dialysis-related peritonitis in an elderly patient
Rheumatology Sys. Review
Case report of cefotaxime treatment for peritoneal dialysis-related peritonitis in an elderly patient Elderly patient on peritoneal dialysis recovered after cefotaxime treatment
This case report describes the treatment of an elderly patient with peritoneal dialysis-related peritonitis using cefotaxime. The patient re…
An elderly patient with peritoneal dialysis-related peritonitis recovered after receiving cefotaxime treatment in a case report.
Case Report and Review of Recurrent Dysplasia Epiphysealis Hemimelica After Surgery
Rheumatology Sys. Review
Case Report and Review of Recurrent Dysplasia Epiphysealis Hemimelica After Surgery One patient's surgery failed at three months, showing how age and incomplete removal cause recurrence
This case report and literature review describes a patient with recurrent Dysplasia Epiphysealis Hemimelica 3 months after surgical interven…
A single patient saw the condition return within three months after surgery, bringing back pain and stiffness. This case highlights the need…
Core set domains capture SLE treatment response in 89.5% of cases at week 52
Rheumatology RCT
Core set domains capture SLE treatment response in 89.5% of cases at week 52 Core set domains capture most lupus disease activity in a global trial
This phase III randomized controlled trial evaluated subjects with Systemic Lupus Erythematosus across a global setting. The study compared …
A global trial found that a core set of domains captured most lupus disease activity without missing important patient responses.
Meta-analysis finds hydroxychloroquine does not reduce most pregnancy complications in SLE
Rheumatology Meta-analysis
Meta-analysis finds hydroxychloroquine does not reduce most pregnancy complications in SLE Hydroxychloroquine May Lower Risk of Fetal Growth Restriction in Lupus Pregnancy
This meta-analysis of observational studies and RCTs assessed hydroxychloroquine use in pregnant women with SLE. It found no significant red…
In lupus pregnancies, hydroxychloroquine was linked to lower risks of fetal growth restriction and gestational diabetes, but not other compl…
Systematic review and meta-analysis of Wuqinxi for knee osteoarthritis joint function
Rheumatology Meta-analysis
Systematic review and meta-analysis of Wuqinxi for knee osteoarthritis joint function Wuqinxi exercise improves knee function and muscle strength in osteoarthritis patients
This systematic review and meta-analysis evaluated Wuqinxi (WQX) in patients with knee osteoarthritis. The analysis pooled data from 809 par…
A review of eight hundred and nine patients found that Wuqinxi exercise significantly improved knee function and muscle strength compared to…
Systematic review of acupuncture for sepsis-associated acute gastrointestinal injury
Rheumatology Meta-analysis
Systematic review of acupuncture for sepsis-associated acute gastrointestinal injury Acupuncture helped some sick patients feel better but did not save more lives in this review
This systematic review and meta-analysis synthesized evidence on adjunctive acupuncture for sepsis-associated acute gastrointestinal injury …
This review looked at acupuncture for very sick people with stomach problems caused by sepsis. While it helped lower inflammation and improv…
FDA Approves Rinvoq Lq (upadacitinib) for Polyarticular Juvenile Idiopathic Arthritis
Rheumatology FDA Approval
FDA Approves Rinvoq Lq (upadacitinib) for Polyarticular Juvenile Idiopathic Arthritis FDA approves new oral drug Rinvoq Lq for children with arthritis.
The FDA approved Rinvoq Lq (upadacitinib) for patients 2 years and older with active polyarticular juvenile idiopathic arthritis after inade…
The FDA approved Rinvoq Lq (upadacitinib) for children ages 2 and older with active polyarticular juvenile idiopathic arthritis (pJIA) who d…
FDA Approves Tyenne (tocilizumab-aazg) for Multiple Inflammatory Conditions
Rheumatology FDA Approval
FDA Approves Tyenne (tocilizumab-aazg) for Multiple Inflammatory Conditions FDA approves new biosimilar drug Tyenne for arthritis and other conditions.
The FDA approved Tyenne (tocilizumab-aazg), an IL-6 receptor antagonist, for rheumatoid arthritis, giant cell arteritis, polyarticular and s…
The FDA approved Tyenne, a biosimilar to tocilizumab, for several inflammatory conditions including rheumatoid arthritis and giant cell arte…